0001104659-20-042006.txt : 20200401
0001104659-20-042006.hdr.sgml : 20200401
20200401185226
ACCESSION NUMBER: 0001104659-20-042006
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200330
FILED AS OF DATE: 20200401
DATE AS OF CHANGE: 20200401
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Graham G. Walmsley
CENTRAL INDEX KEY: 0001777517
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38944
FILM NUMBER: 20766907
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET, SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 415-801-8100
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET, SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akero Therapeutics, Inc.
CENTRAL INDEX KEY: 0001744659
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 170 HARBOR WAY
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-487-6488
MAIL ADDRESS:
STREET 1: 170 HARBOR WAY
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
a4.xml
4
X0306
4
2020-03-30
0
0001744659
Akero Therapeutics, Inc.
AKRO
0001777517
Graham G. Walmsley
C/O AKERO THERAPEUTICS, INC.,
170 HARBOR WAY, 3RD FLOOR
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Common Stock
2020-03-30
4
M
0
2168
19.97
A
2168
D
Stock Option (Right to Buy)
19.97
2019-11-08
4
M
0
2168
0
D
2029-11-07
Common Stock
2168
23832
D
This option shall vest and become exercisable in 36 equal monthly installments, commencing on November 8, 2019.
/s/ Jonathan Young, attorney-in-fact
2020-04-01